ACRX AcelRx Pharmaceuticals
WatchlistAcelRx Pharmaceuticals News
12 Health Care Stocks Moving In Monday's After-Market Session
GainersSenesTech (NASDAQ:SNES) stock rose 42.0% to $2.67 during Monday's after-market session. TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 17.71% to $0.49. The market value of their outstanding s
AcelRx Pharmaceuticals Files for $150M Mixed Shelf
12 Health Care Stocks Moving In Friday's After-Market Session
GainersForte Biosciences (NASDAQ:FBRX) shares increased by 11.8% to $0.5 during Friday's after-market session. Today's trading volume for this security ended up closing at 287.3K shares, which is 905.
AcelRx Pharmaceuticals GAAP EPS of -$0.08 Beats by $0.20, Revenue of $0.12M Misses by $0.01M
Earnings Scheduled For November 8, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter. • Evotec (NASDAQ:EVO) is estimated to report quarterly loss at $0.05 per share on reve
AcelRx Pharmaceuticals Q3 2023 Earnings Preview
AcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersClene (NASDAQ:CLNN) stock increased by 9.4% to $0.47 during Wednesday's after-market session. The market value of their outstanding shares is at $60.7 million. AcelRx Pharmaceuticals (NASDAQ:AC
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersReshape Lifesciences (NASDAQ:RSLS) stock rose 30.2% to $0.27 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 1.8 million shares, which is 104
On Oct 18, Acelrx Pharmaceuticals Received Written Notice From Nasdaq Notifying Co That It Is Not In Compliance With Minimum Bid Price Requirement; Will Evaluate Available Options To Regain Compliance With Minimum Bid Price Requirement
On Oct 18, Acelrx Pharmaceuticals Received Written Notice From Nasdaq Notifying Co That It Is Not In Compliance With Minimum Bid Price Requirement; Will Evaluate Available Options To Regain Compliance
AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study
Investigational Device Exemption (IDE) approval by the U.S. Food and Drug Administration (FDA) allows AcelRx to begin pivotal study of Niyad Single registration study with pre-agreed upon endpoints planned to
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
UpgradesFor Invitation Homes Inc (NYSE:INVH), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the second quarter, Invitation Homes had an EPS of $0.44, compared to year-a
Alliance Global Partners Initiates Coverage On AcelRx Pharmaceuticals With Buy Rating, Announces Price Target of $4.25
Alliance Global Partners analyst James Molloy initiates coverage on AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy rating and announces Price Target of $4.25.
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersTransCode Therapeutics (NASDAQ:RNAZ) shares increased by 76.2% to $1.17 during Monday's pre-market session. The company's market cap stands at $2.3 million. Biophytis (NASDAQ:BPTS) shares moved
Baidu To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday
Goldman Sachs increased the price target for Constellation Brands, Inc. (NYSE:STZ) from $275 to $305. Goldman Sachs analyst Bonnie Herzog maintained a Buy rating. Constellation shares fell 0.8% to $
HC Wainwright & Co. Maintains Buy on AcelRx Pharmaceuticals, Lowers Price Target to $5
HC Wainwright & Co. analyst Ed Arce maintains AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and lowers the price target from $8 to $5.
AcelRx CEO Buys 10,000 Shares
AcelRx Pharmaceuticals(ACRX.US) Officer Buys US$7,950 in Common Stocks
$AcelRx Pharmaceuticals(ACRX.US)$ Officer Angotti Vincent J. purchased 10,000 shares of Common Stocks on Sep 11, 2023 at an average price of $0.795 for a total value of $7,950.Source: Announcement Wha
AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference
AcelRx Pharmaceuticals (ACRX.US) Chief Medical Officer sold 17,000 common shares worth approximately $19,200
On August 26, it was reported that according to documents disclosed by the US Securities and Exchange Commission (SEC) on August 25, $ACRX Pharmaceuticals (ACRX.US) $ Chief Medical Officer Palmer Pamela P sold 17,000 common stock shares at an average price of $11134 per share on August 24 and 25, worth about 19,200 US dollars. Image source: SEC official website What is a statement of changes in shareholding? The SEC requires insiders of listed companies to publicly disclose their securities transactions and holdings when the insiders' holdings change